Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

Blood biomarker associated with prevalence, severity of Alzheimer’s, but not risk of development

April 6, 2011
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.

Leave a Reply


Study: Virtual colonoscopy effective screening tool for adults over 65

Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Aspirin as good as Plavix for poor leg circulation: study

(HealthDay) -- Aspirin works as well as Plavix in patients with blocked leg arteries, a new European study finds.

Study: Colonoscopy cuts colon cancer death risk

(AP) -- Millions of people have endured a colonoscopy, believing the dreaded exam may help keep them from dying of colon cancer. For the first time, a major study offers clear evidence that it does.

ACGME announces plan to transform graduate medical education

The Accreditation Council for Graduate Medical Education (ACGME) today announced major changes in how the nation's medical residency programs will be accredited in the years ahead, putting in place an outcomes-based evaluation system where the doctors of tomorrow will be measured for their competency in performing the essential tasks necessary ...

US drafts plan to fight feared Alzheimer’s disease

(AP) -- The Obama administration declared Alzheimer's "one of the most feared health conditions" on Wednesday as it issued a draft of a new national strategy to fight the ominous rise in this mind-destroying disease.

Phobia’s effect on perception of feared object allows fear to persist

The more afraid a person is of a spider, the bigger that individual perceives the spider to be, new research suggests.

FDA panel backs previously rejected obesity pill

(AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.